1Li QL, Ito K, Sakaura C, et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell, 2002,109:113-124.
2Fang W, Piao Z, Simon D, et al. Mapping of a minimal deleted region in human hepatocellular carcinoma to 1p36.13-p36.33 and mutational analysis of the RIZ(PRDM2) gene localized to the region. Gene Chromosomes Cancer, 2000,28:269-275.
3Bangsow C, Rubins N, Glusman G, et al. The RUNX3 gene-sequence, structure and regulated expression. Gene, 2001,279:221-232.
4Zaidi SK, Sullivon AJ, Wijnen AJV, et al. Integration of Runx and Smad regulatory signals at transcriptionally active subnuclear sites. Proc Natl Acad Sci USA, 2002,99:8048-8053.
5Song BC, Chung YH, Kim JA, et al. Transforming growth factor-beta as a useful serologic marker of small hepatocellular carcimoa. Cancer, 2002,9:175-180.
1Simpson DJ, Hibberts NA, Mc Nicol AM, et al. Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island. Cancer Res, 2000, 60:1211-1216.
2Fujimoto J, Yasui W, Tahara H, et al. DNA hypermethylation at the pS2 promoter region is associated with early stage of stomach carcinogenesis. Cancer Lett, 2000,149:125-134.
3Lubomierski N, Kersting M, Bert T, et al. Tumor suppressor genes in the 9p21 gene cluster are selective targets of inactivation in neuroendocrine gastroenteropancreatic tumors. Cancer Res, 2001,61:5905-5910.
4Herman JG, Graff JR, Myohanen S, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA, 1996,93:9821-9826.
5Magee AI,Buxton RS. Transmembrane molecular assemblies regulated by the greater cadherin family. Curr Opin Cell Biol, 1991,3:854-861.
6Shimoyama Y, Hirohashi S. Cadherin intercellular adhesion molecule in hepatocellular carcinomas: loss of E-cadherin expression in an undifferentiated carcinoma. Cancer Lett, 1991,57:131-135.
7Razin A, Cedar H. DNA methylation and gene expression. Microbiol Rev, 1991,55:451-458.
8Baylin SB, Herman JG, Graff JR, et al. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res, 1998,72:141-196.
9Si HX, Tsao SW,Lam KY, et al. E-cadherin expression is commonly downregulated by CpG island hypermethylation in esophageal carcinoma cells. Cancer Lett, 2001,173:71-78.
4Yang N, Zhang L, Zhang Y,et al. An important role for RUNX3 in human L1 transcription and retmtransposition [ J ]. Nuclear Acids Res, 2003, 31( 16): 4929-4940.
6Miyazono K, Suzuki H, lroamura T. Regulation of TGF-beta signaling and its roles in progression of tumors [ J ]. Cancer Sci, 2003,94 ( 3 ) : 230-234.
7Hsu DK, Dowling CA, Jeng KC, et al. Galectin-3 expression is in- duced in cirrhotic liver and hepatocellular carcinoma [ J ]. Cancer, 1999,81 (4) :519-526.
8Chi XZ, Yang JO, Lee KY, et al. RUNX3 suppresses gastric epithe- lial cell growth by inducing p21 (WAF1/Cipl) expression incoopera- tion with transforming growth factor beta-activated SMAD [ J ]. Mol Cell Biol, 2005, 25 ( 18 ) : 8097-8110.
9Takenaka Y, Inohara H, Yoshii T, et al. Malignant transformation of thyroid follicular cells by Galectin-3 [ J ]. Cancer Lett, 2003,195 ( 1 ) : 111-119.
